UnknownPhase 2NCT04541771

The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants

Studying Necrotizing enterocolitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital and Institute of Child Health, Multan
Principal Investigator
summera tabasum
CH&ICH
Intervention
Lactobacillus Reuteri DSM 17938(drug)
Enrollment
120 enrolled
Eligibility
All sexes
Timeline
20202021

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04541771 on ClinicalTrials.gov

Other trials for Necrotizing enterocolitis

Additional recruiting or active studies for the same condition.

See all trials for Necrotizing enterocolitis

← Back to all trials